Karl Geza Verebey, PhD, DABFT, HCLD

Karl Verebey

Title: Toxicologist, Pharmacologist, Educator
Company: Ammon Analytical Laboratory
Location: River Vale, New Jersey, United States

Karl Geza Verebey, PhD, DABFT, HCLD, Toxicologist, Pharmacologist and Educator at Ammon Analytical Laboratory, has been recognized by Marquis Who’s Who Top Educators for dedication, achievements, and leadership in medical research.

A respected leader in the medical community, Dr. Verebey is credited with analyzing more than 300 forensic toxicology and medico-legal cases throughout his career. He has also served as an expert in drugs of abuse testing, alcohol, drug-induced psychopharmacology, clinical pharmacology, and forensic toxicology in six states. Dr. Verebey was most recently recognized as the director of toxicology with the Ammon Analytical Laboratory from 1999 to 2003. He previously served as the president and director of LeadTech Corp., senior legal consultant in forensic toxicology, pharmacology and behavior with the Biobehavioral Research Foundation Inc., director of toxicology with the Institute for Basic Research, chief toxicologist with the Department of Health with the City of New York, NY, and clinical laboratory director with the Psychiatric Diagnostic Laboratory of America.

Early in his career, Dr. Verebey served as a laboratory technologist with the U.S. Army Medical Corps for two years. Upon completing a Bachelor of Arts in psychology at Hunter College in 1965, he attended the City University of New York, where he received a Master of Arts in molecular biology in 1968. He went on to complete a PhD in pharmacology and biochemistry with Weill Cornell Medicine at Cornell University in 1972. A licensed director in several fields, Dr. Verebey also completed a postdoctoral fellowship in neurology.

As a medical researcher, Dr. Verebey was credited with devising a test known as the “filter paper collection” technique for lead poisoning screening, which continues to be a preferred method nearly 30 years later. Additionally, he has performed a great deal of research on methadone. He has contributed more than 100 articles to scientific journals, as well as several chapters to books. A committed educator, Dr. Verebey has also delivered lectures and abstracts at scientific meetings. His most well-known publications include “A New Approach to Treating Arthritic Conditions on a Long-term Basis, Without Adverse Side Effects,” “Possible Mechanisms of Complications of Angiography” and “Inhibition of Diphenylhydantoin Metabolism in Rats and Rat Liver Microsomes by Antitubercular Drugs.”

In recognition of his contributions to the field of health care, Dr. Verebey was selected to receive a Worldwide Lifetime Achievement Award in 2017. He has been featured in a wide range of honors publications, including Who’s Who in America, Who’s Who in Medicine and Healthcare, Who’s Who in the East and Who’s Who in the World.

For more:

Press Release

Lifetime Achievement


Contact Dr. Verebey

Leave a Reply